By now you’ve probably heard of the recent announcement by the U.S. Department of Education that it is pulling all of its funding from a research institute focused on the prevention and treatment of diabetes.
That’s because of a study that found that its researchers were not getting enough funding to carry out the kind of rigorous studies that they would have been able to perform on a larger scale.
“This is a serious issue and there’s no excuse for it,” said John Langer, a professor of pediatrics at the University of Pennsylvania and an expert on the relationship between diet and diabetes.
The U.K.-based Diabetes Education Trust (DEWT), which funds most of the research in the U, said in a statement that it “categorically” opposes the DOE decision and that it will work to make sure the researchers continue to get funding for their work.
“We will work with the U to ensure that all appropriate steps are taken to ensure their continued support,” DEWT said in the statement.
But some scientists said the move was a step in the right direction.
The new funding from DEWT and the U is likely to help a group of researchers that study how insulin and the blood glucose levels in people with type 2 diabetes, called type 1 diabetes, and people who have never had diabetes, or people with Type 2 and Type 1 who have it, such as obese adults.
The researchers have been looking for ways to use data from the diabetes community to better understand how the two diseases affect health.
The study was funded by the National Institutes of Health, the U and the Department of Defense, which will now receive the funding.
The research that DEWT funded has focused on using blood glucose to help people with the disease, such people may not be able to see their blood glucose in real time, but their insulin does.
That means their blood sugar levels will tell them whether their insulin is working or not.
“It’s a great first step, but there are other ways to get the blood sugar readings in real-time,” said Dr. David McBride, a researcher at Duke University who is also a DEWT board member.
“If you can get a better picture of the situation and what’s going on, that’s really going to help you to make better decisions about insulin.”
Dr. Jonathan Gold, an assistant professor at the Harvard Medical School who has studied the relationship of diabetes and the body, said that the researchers’ focus on Type 1 diabetes is a significant step forward.
“The diabetes community has been looking at these questions for decades and there are not a lot of new ideas.
I’m very excited that the NIH has finally taken this on,” he said.”
I’m not sure what DEWT is going to do with it, but I think it’s an important first step,” said Katherine J. Lappin, a pediatric endocrinologist at the Children’s Hospital of Philadelphia who was not involved in the study.
“This study shows that the blood test is a good way to make an educated diagnosis.”
While the study was published in the journal Pediatrics, DEWT did not immediately respond to a request for comment.
The researchers did not identify the person who was involved in this research but told Reuters that they were working with the National Center for Complementary and Alternative Medicine, which is funded by DEWT.
“As we are no longer accepting funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), we are also no longer providing support for research that has directly contributed to the advancement of the diabetes research community,” the group said in its statement.
The study was conducted by researchers at the National Diabetes Education Foundation (NDEF), a group that is part of the DEWT’s diabetes research arm.
It was funded through grants from the U., the NIDDK and the NIH.
“It’s great news for people with diabetes,” said Diane Kastel, a diabetes educator and co-founder of the NDEF.
“They are now able to have their blood test taken, which was a really challenging part of their diabetes diagnosis.”
The researchers also found that the group was having problems recruiting researchers.
“We have been trying to recruit a lot more people to this project,” said Michael McQuade, an associate professor of medicine at the Baylor College of Medicine and the study’s lead author.
“There is a huge need for more people with this disease to participate in studies and more research to understand it.”